Approximately 213 million individuals throughout the European Union and North America are living with the deleterious effects of traumatic brain injury (TBI) (Tagliaferri et al. 2006).
Currently, the treatment options available are limited, without any disease modifying treatment (Carney et. al. 2017).
Appropriate dose of near infra-red light is known to provide significant therapeutic benefit by process of photobiomodulation (Karu 2005).
To develop functional direct contact intra-cranial and intra-spinal phototherapy devices, with a view to its potential use as a disease modifying treatment in traumatic brain injury (TBI).
We believe that optimised delivery of new infra-red light directly to brain tissues may augment the already proposed improvements to the neuro-reparative response within the context of TBI, where even modest benefits could translate into significant patient outcome.